First AD

Second AD

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Updates and Advances in the Management of HS

 Special Reports page is a resource for live video interviews with leading clinical experts and investigators from major medical conferences and significant events throughout the year.

News Network

An expert in dermatology reviews the phase 3 SUNSHINE and SUNRISE trials evaluating the use of secukinumab given in 2-week intervals in patients with HS and shares clinical pearls for managing  the condition.

SUNSHINE and SUNRISE Trials in HS

Overview of Hidradenitis Suppurativa (HS): A Multifactorial Disease

Approaching Treatment and Addressing Unmet Needs for Mild-to-Moderate HS

Role of Immunomodulation in HS Treatment

Emerging Agents for the Management of HS

Overview and Diagnosis of Hidradenitis Suppurativa (HS)

Role of TNF-α Inhibitors in Moderate-to-Severe HS Treatment

Unmet Needs and Emerging Therapies in HS

Clinical Pearls for the Management of HS

Quality of Life for Patients With Hidradenitis Suppurativa (HS)

Diagnosis of HS

Treatment Options for HS

Emerging Therapy for Patients With HS

Clinical Pearls for Providers Treating HS